Scandion Oncology
Overcoming cancer drug resistance
Navbar
About us
Executive Management
Board of Directors
Clinical Advisory Board
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
Patents
Press releases
Investors & Media
Share information
Financial Reports
Annual reports
Interim reports
Year-end reports
Presentations
Media
Image library
Video library
Analyst Coverage
Prospectuses
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
Events
Financial calendar
General meetings
Contact
Career
Business development
Skip to content
Investor Call
Watch now
Watch the presentation from the Investor call on June 10, 2022
Post navigation
Redeye Growth Day 2022
DAF Interview
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Read our cookie policy
Settings
Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year.
Read our cookie policy
Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.
Save
Accept all